Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37)

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 180-186

  Hosokawa, Yuka A ^a,b   Hosokawa, Hitoshi ^a,b   Chen, Chuan ^a,b   Leahy, Jack L ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

animal models noninsulin dependent diabetes mellitus; fasting; insulin content; islet of Langerhans glucose metabolism; proinsulin biosynthesis

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-37]; GLUCOSE; INSULIN; PROINSULIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SYNTHESIS; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PRIORITY JOURNAL; RAT;

EID: 0030045655     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118387     Document Type: Article

References (44)

1. Leahy, J. L. 1990. Natural history of B-cell dysfunction in NIDDM. Diabetes Care 13 992-1010.
2. Porte, D., Jr. 1991 β-cells in type II diabetes mellitus. Diabetes 40:166-180
3. Leahy, J. L., S. Bonner-Weir, and G. C. Weir. 1992. Beta-cell dysfunction induced by chronic hyperglycemia: current ideas on the mechanism of the impaired glucose-induced insulin secretion Diabetes Care. 15:442-455.
4. Halter, J. B , R. J. Graf, and D. Porte. Jr. 1979. Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J. Clin. Endocrinol. & Metab 48.946-954.
5. Ward, W. K , D C. Bolgiano, B. McKnight, J B. Halter, and D. Porte, Jr. 1984. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin Invest. 74:1318-1328.
6. Leahy, J. L , L. M. Bumbalo, and C. Chen. 1993. Beta-cell hypersensitivily for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats Diabetologia 36:1238-1244.
7. Leahy, J. L., L. M. Bumbalo, and C. Chen. 1994. Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43:173-179.
8. Sako, Y., and V. E. Griil. 1990. Coupling of B-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes. 39:1580-1583.
9. Bjorklund, A., and V. Grill. 1993. β-cell insensitivity in vitro: reversal by diaxoxide entails more than one event m stimulus-secretion coupling. Endocrinology. 132:1319-1328.
10. Greenwood, R. H , R. F. Mahler, and C. N. Hales. 1976. Improvement in insulin secretion in diabetes after diazoxidc. Lancet i:444-447.
11. Malaisse, W. J., F. Malaisse-Lagae, and P H. Wright. 1967 Effect of fasting upon insulin secretion in the rat. Am. J. Physiol. 213:843-848.
12. Grey, N. J., S. Goldring, and D. M. Kipnis 1970 The effect of fasting, diet, and actinomycin D on insulin secretion in the rat. J. Clin. Invest 49:881-889.
13. Levy, J , A. Herchuelz, A. Sener, and W. J Malaisse. 1976. The stimulus-secretion coupling of glucose-induced insulin release. XX. Fasting: a model of altered glucose recognition by the β-cell. Metab. Clin. Exp. 25:583-591.
14. 3H]-L-phenylalanine into proinsulin-insulin and total protein in isolated rat pancreatic islets. Horm. Metab. Res. 8:261-266.
15. Koranyi, L., R Bourey. J. Turk, M Meuckler, and M. A. Permutt. 1992. Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2). proinsulin, and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycemia and dexamethasone treatment. Diabetologia. 35.1125-1132.
16. Féry, F., and E. O. Balasse. 1994. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes. 43:1418-1425.
17. Mosjov, S., G. C. Weir, and J. F. Habener. 1987. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79:616-619.
18. Thorens, B., and G. Waeber. 1993. Glucagon-like peptide I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42: 1219-1225.
19. Weir, G. C., S. Mojsov, G. K. Hendrick. and J. F. Habener. 1989. Glucagonlike peptide 1 (7-37) actions on endocrine pancreas. Diabetes. 38:338-342.
20. Bonner-Weir, S., D. F. Trent, and G. C. Weir 1983. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J. Clin Invest. 71:1544-1553.
21. Gotoh, M., T. Maki, S. Satomi, J. Porter, S. Bonner-Weir, C. J. O'Hara, and A. P. Monaco. 1987. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation. 43:725-730.
22. Weir, G. C., S. D. Knowlton, and D. B Martin. 1974. Glucagon secretion from the perfused rat pancreas: studies with glucose and catecholamines. J. Clin. Invest. 54:1403-1412.
23. Albano, J. D. M., R. P. Ekins, G. Maritz, and R. C. Turner. 1972. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol. 70:487-509.
24. Ashcroft, S. J. H., L. C. C. Weerasighe, J. M. Bassett, and P. J. Randle. 1972. The pentose cycle and insulin release in mouse pancreatic islets. Biochem. J. 126:525-532.
25. Alarcón, C., B. Lincoln, and C. J. Rhodes. 1993. The biosynthesis of the subtilisin-related proprotein convertase PC3, but not that of the PC2 cortvertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. J. Biol. Chem 268:4276-4280.
26. Alarcón, C., J. L. Leahy, G. T. Schuppin, and C. J Rhodes 1995. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of noninsuhn-dependent diabetes mellitus. J. Clin. Invest. 95.1032-1039.
27. Brockenbrough, J S., G. C. Weir, and S. Bonner-Weir. 1988. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes. 37:232-236.
28. Bonner-Weir, S , D. Deery, and G. C. Weir. 1986. Growth of regenerating islet tissue is enhanced by VMH lesions. Diabetes. 35(Suppl. 1):97a. (Abstr.)
29. Williams, G. 1994. Management of non-insulin-dependent diabetes mellitus. Lancet 343:95-100.
30. Hosker, J. P., S. Kumar, C. Gordon, D. Bhatnagar, M. France, and A. J. Boulton. 1993. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity. Diabetic Med. 10:509-513.
31. Bjorkman, O., and L. S. Eriksson. 1985 Influence of a 60-hour fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans. J Clin. Invest 76:87-92.
32. Malaisse, W. J., A. Sener, and J. Levy. 1976. The stimulus-secretion coupling of glucose-induced insulin release. XXI. Fasting-induced adaption of key glycolytic enzymes in isolated islets. J. Biol. Chem. 251:1731-1737.
33. Burch, P. T., M. D. Trus, D K. Berner, A. Leontire, K. C. Zawalich, and F. M. Matschinsky. 1981. Adaption of glycolytic enzymes: glucose use and insulin release in rat pancreatic islets during fasting and refeeding. Diabetes. 30 923-928
34. Meglasson, M. D., and F. M. Matschinsky. 1986. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev. 2:163-214
35. Bonner-Weir, S., L. A. Baxter, G. T. Schuppin, and F. E Smith. 1993. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715-1720.
36. Leahy, J. L., and G. C. Weir. 1991 B-cell dysfunction in hyperglycaemic rat models. Recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabetologia 34:640-647.
37. Ashcroft, S. J. H., J. Bunce, M. Lowry, S. E. Hansen, and C J. Hedeskov. 1978. The effect of sugars on (pro)insulin biosynthesis. Biochem. J. 174: 517-526.
38. Malaisse, W. J. 1984. Hexose metabolism in pancreatic islets. Inhibition of hexokinase. Biochem. J. 223:447-453.
39. Hosokawa, H., Y. A Hosokawa, and J L Leahy. 1995. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomy rats Diabetes. 44:1328-1333.
40. Becker, T. C., H. BeltrandelRio, R. J. Noel, J. H. Johnson, and C. B Newgard. 1994. Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels J Biol Chem. 269:21234-21238.
41. Ishihara, H., T. Asano, K. Tsukuda, H. Katagiri, K. Inukai, M. Anai, M Kikuchi, Y. Yazaki, J.-i. Miyazaki, and Y. Oka 1994. Overexpression of hexokinase I but not GLUT1 glucose transporter alters concentration dependence of glucose-stimulated insulin secretion in pancreatic β-cell line MIN6. J. Biol. Chem 269:3081-3087.
42. Chen, C., L. M. Bumbalo, and J. L. Leahy. 1994. Increased catalytic activity of glucokinase in isolated islets from hyperinsulinemic rats. Diabetes 43: 684-689.
43. Milburn, J. L., Jr., H. Hirose, Y. H. Lee, Y. Nagasawa, A. Ogawa, M Ohneda, H. BeltrandelRio, C. B. Newgard, J. H. Johnson, and R. H. Unger. 1995. Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids J Biol Chem. 270:1295-1299.
44. Giroix, M.-H., A. Sener, D. Bailbe, B. Portha, and W. J. Malaisse. 1990. Impairment of the mitochondrial oxidative response to D-glucose in pancreatic islets from adult rats injected with streptozotocin during the neonatal period. Diabetologia. 33:654-660.